These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Intracranial metastatic melanoma: correlation between MR imaging characteristics and melanin content. Isiklar I; Leeds NE; Fuller GN; Kumar AJ AJR Am J Roentgenol; 1995 Dec; 165(6):1503-12. PubMed ID: 7484597 [TBL] [Abstract][Full Text] [Related]
3. Isolated cerebral susceptibility artefacts in patients with malignant melanoma: metastasis or not? Gramsch C; Göricke SL; Behrens F; Zimmer L; Schadendorf D; Krasny A; Forsting M; Schlamann MU Eur Radiol; 2013 Sep; 23(9):2622-7. PubMed ID: 23670820 [TBL] [Abstract][Full Text] [Related]
4. Assessment of Melanin Content and its Influence on Susceptibility Contrast in Melanoma Metastases. Straub S; Laun FB; Freitag MT; Kölsche C; von Deimling A; Denoix M; Bendszus M; Schlemmer HP; Ladd ME; Schneider TM Clin Neuroradiol; 2020 Sep; 30(3):607-614. PubMed ID: 31396654 [TBL] [Abstract][Full Text] [Related]
5. Use of Susceptibility-Weighted Imaging (SWI) in the Detection of Brain Hemorrhagic Metastases from Breast Cancer and Melanoma. Franceschi AM; Moschos SJ; Anders CK; Glaubiger S; Collichio FA; Lee CB; Castillo M; Lee YZ J Comput Assist Tomogr; 2016; 40(5):803-5. PubMed ID: 27636126 [TBL] [Abstract][Full Text] [Related]
6. [Cerebral MR imaging of malignant melanoma]. Breckwoldt M; Bendszus M Radiologe; 2015 Feb; 55(2):113-9. PubMed ID: 25589420 [TBL] [Abstract][Full Text] [Related]
11. The diagnostic value of postcontrast susceptibility-weighted imaging in the assessment of intracranial brain neoplasm at 3T. Kang H; Jang S Acta Radiol; 2021 Jun; 62(6):791-798. PubMed ID: 32664747 [TBL] [Abstract][Full Text] [Related]
12. Susceptibility artifacts in ruptured intracranial dermoid cysts: a poorly understood but important phenomenon. Sood S; Gupta R Neuroradiol J; 2014 Dec; 27(6):677-84. PubMed ID: 25489890 [TBL] [Abstract][Full Text] [Related]
13. Susceptibility artifact morphology is more conspicuous on susceptibility-weighted imaging compared to T2* gradient echo sequences in the brains of dogs and cats with suspected intracranial disease. La Rosa C; Donato PD; Specchi S; Bernardini M Vet Radiol Ultrasound; 2023 May; 64(3):464-472. PubMed ID: 36633010 [TBL] [Abstract][Full Text] [Related]
14. Quantitative susceptibility-weighted imaging in presence of strong susceptibility sources: Application to hemorrhage. De A; Sun H; Emery DJ; Butcher KS; Wilman AH Magn Reson Imaging; 2022 Oct; 92():224-231. PubMed ID: 35772582 [TBL] [Abstract][Full Text] [Related]
15. Vascular white matter lesions negatively correlate with brain metastases in malignant melanoma-Results from a retrospective comparative analysis. Berk BA; Hering K; Kortmann RD; Hoffmann KT; Ziemer M; Seidel C Clin Neurol Neurosurg; 2019 May; 180():117-121. PubMed ID: 30978511 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic Value of Fractal Analysis for the Differentiation of Brain Tumors Using 3-Tesla Magnetic Resonance Susceptibility-Weighted Imaging. Di Ieva A; Le Reste PJ; Carsin-Nicol B; Ferre JC; Cusimano MD Neurosurgery; 2016 Dec; 79(6):839-846. PubMed ID: 27332779 [TBL] [Abstract][Full Text] [Related]
17. High signal-intensity abnormalities in susceptibility-weighted imaging for primary intracerebral hemorrhage. Liang JJ; Lei L; Zeng YP; Xiao ZM Int J Neurosci; 2019 Sep; 129(9):842-847. PubMed ID: 30724645 [No Abstract] [Full Text] [Related]
18. Early imaging radioresponsiveness of melanoma brain metastases as a predictor of patient prognosis. Zubatkina I; Ivanov P J Neurosurg; 2018 Aug; 129(2):354-365. PubMed ID: 28841116 [TBL] [Abstract][Full Text] [Related]
19. Propensity for different vascular distributions and cerebral edema of intraparenchymal brain metastases from different primary cancers. Mampre D; Ehresman J; Alvarado-Estrada K; Wijesekera O; Sarabia-Estrada R; Quinones-Hinojosa A; Chaichana KL J Neurooncol; 2019 May; 143(1):115-122. PubMed ID: 30835021 [TBL] [Abstract][Full Text] [Related]